Global Chemotherapy Infusion Set Market Size By Type (With Filter, Without Filter), By Application (Hospital, Medical Device Distributor), By Region, And Segment Forecasts, 2023 to 2032

The Global Chemotherapy Infusion Set Market was valued at USD 1.42 billion in 2023 and is projected to reach USD 2.37 billion by 2031, growing at a CAGR of 6.6% during the forecast period of 2023 to 2031. This growth is driven by the rising global incidence of cancer, increased demand for targeted drug delivery systems, and technological innovations in infusion devices. Chemotherapy infusion sets play a critical role in ensuring precise, controlled, and safe administration of antineoplastic drugs, improving treatment efficacy and patient outcomes across oncology care settings.

Drivers:

Rising Global Cancer Prevalence

An increase in the number of cancer diagnoses globally is a primary driver. According to WHO estimates, cancer is among the leading causes of death worldwide, and this upward trend necessitates reliable and safe chemotherapy delivery systems, propelling demand for infusion sets.

Technological Advancements in Infusion Devices

Modern chemotherapy infusion sets incorporate features like air-elimination filters, needle-free connectors, and integrated safety mechanisms to prevent drug leakage and accidental exposure. These enhancements improve operational safety and accuracy, accelerating market growth.

Increased Adoption in Ambulatory and Homecare Settings

Growing preferences for at-home chemotherapy treatments due to convenience and cost-effectiveness are increasing the demand for portable and user-friendly infusion sets, driving segment expansion.

Restraints:

High Cost of Chemotherapy and Associated Equipment

The cost-intensive nature of chemotherapy drugs and infusion devices can limit adoption, particularly in low- and middle-income countries. In addition, reimbursement challenges in some healthcare systems may restrict accessibility.

Risks of Infusion-Related Complications

Despite design improvements, chemotherapy infusion sets can be associated with risks like phlebitis, infections, or extravasation, which require trained personnel and monitoring, potentially deterring usage in non-hospital settings.

Opportunity:

Expansion in Emerging Economies

Rising healthcare expenditure, cancer screening initiatives, and improvements in healthcare infrastructure across emerging markets such as India, Brazil, and Southeast Asia are creating growth opportunities for chemotherapy infusion set providers.

Personalized Chemotherapy & Oncology Pipeline Innovations

The advancement of personalized medicine and targeted therapies requires delivery systems that ensure precise dosing, opening up new avenues for innovation in infusion set design.

Market by System Type Insights:

The gravity-based infusion set segment dominated the market in 2023 due to its cost-effectiveness, widespread use in developing regions, and minimal operational complexity. However, the pump-based infusion set segment is expected to witness the highest growth rate through 2031, driven by rising demand for precision in chemotherapy delivery and integration with electronic monitoring systems for enhanced safety.

Market by End-use Insights:

Hospitals held the largest market share in 2023, supported by the availability of specialized oncology departments, trained healthcare providers, and reimbursement-backed treatments. However, homecare settings are anticipated to grow significantly during the forecast period, driven by the increasing preference for remote cancer care and the availability of portable infusion solutions.

Market by Regional Insights:

North America led the global chemotherapy infusion set market in 2023, attributed to advanced healthcare infrastructure, high cancer incidence, and significant investment in oncology research. Asia-Pacific, however, is poised for the fastest growth through 2031 due to rising healthcare awareness, government initiatives for cancer screening, and expanding medical infrastructure in countries like China and India.

Competitive Scenario:

Key players in the market include B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Fresenius Kabi AG, Terumo Corporation, Smiths Medical, Nipro Corporation, AngioDynamics Inc., Zyno Medical, and CODAN Companies. These firms are actively engaged in product innovation, strategic collaborations, and global market expansion.

Notable Developments:

In 2023, ICU Medical launched a next-generation chemotherapy infusion set compatible with smart pump technologies to improve safety in high-dose drug administration.

Fresenius Kabi introduced eco-friendly, low-leachate infusion tubing in 2024 to address regulatory demands and sustainability goals.

In 2025, B. Braun announced a partnership with a leading cancer research institute to co-develop customizable infusion systems for targeted oncology therapies.

Scope of Work – Global Chemotherapy Infusion Set Market

FAQs:

1. What is the current market size of the Global Chemotherapy Infusion Set Market?

The market was valued at USD 1.42 billion in 2023.

2. What is the major growth driver of the Global Chemotherapy Infusion Set Market?

The primary growth driver is the increasing global incidence of cancer and the demand for safe and accurate chemotherapy drug delivery systems.

3. Which is the largest region during the forecast period in the Global Chemotherapy Infusion Set Market?

North America held the largest share in 2023, while Asia-Pacific is expected to witness the highest growth rate through 2031.

4. Which segment accounted for the largest market share in the Global Chemotherapy Infusion Set Market?

The gravity-based infusion set segment led the market in 2023 due to its cost-effectiveness and accessibility.

5. Who are the key market players in the Global Chemotherapy Infusion Set Market?

Major players include B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Fresenius Kabi, Terumo Corporation, and Smiths Medical.